CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Open-market buy Director bought 2,000 shares at $4.14 ($8,280)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President, CEO and Director sold 1,522,500 shares at $4.00 ($6,090,000)
- 4 Open-market sale Director sold 1,522,500 shares at $4.00 ($6,090,000)
- 4 Open-market sale 10% owner sold 1,522,500 shares at $4.00 ($6,090,000)
- 4 Open-market buy Director bought 61,841 shares at $4.40 ($272,100)
- 4 Open-market buy Director bought 48,159 shares at $4.00 ($192,636)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 9 of 12 · 235 filings